BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8528356)

  • 1. Serum immunoreactive inhibin levels in polycystic ovarian disease (PCOD) and hypogonadotropic amenorrhea.
    Mizunuma H; Andoh K; Obara M; Yamaguchi M; Kamijo T; Hasegawa Y; Ibuki Y
    Endocr J; 1994 Aug; 41(4):409-14. PubMed ID: 8528356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum immunoreactive inhibin during ovulation induction in women with amenorrhea.
    Takagi T; Mizunuma H; Andoh K; Obara M; Yamaguchi M; Hasegawa Y; Ibuki Y
    Endocr J; 1994 Dec; 41(6):703-8. PubMed ID: 7704095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea.
    Burger CW; Korsen T; van Kessel H; van Dop PA; Caron FJ; Schoemaker J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1126-32. PubMed ID: 3932449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J; Banah M; McCloud P; Hee J; Burger H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA; Groome NP; Baird DT
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Luteal and follicular phase inhibin A and B in regularly cycling women].
    Jakimiuk AJ; Jezierska Z; Tarkowski R; Dziduch P; Tomaszewski J; Haczyński J; Jakowicki JA
    Ginekol Pol; 2001 Dec; 72(12A):1393-7. PubMed ID: 11883285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.
    Buckler HM; McLachlan RI; MacLachlan VB; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1988 Apr; 66(4):798-803. PubMed ID: 3126215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle.
    Reddi K; Wickings EJ; McNeilly AS; Baird DT; Hillier SG
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):547-57. PubMed ID: 2121399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
    Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimeric inhibin: a direct marker of ovarian aging.
    Danforth DR; Arbogast LK; Mroueh J; Kim MH; Kennard EA; Seifer DB; Friedman CI
    Fertil Steril; 1998 Jul; 70(1):119-23. PubMed ID: 9660432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa.
    Luisi S; Ciani V; Podfigurna-Stopa A; Lazzeri L; De Pascalis F; Meczekalski B; Petraglia F
    Gynecol Endocrinol; 2012 Jan; 28(1):34-8. PubMed ID: 21627557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive inhibin levels during ovarian stimulation may predict granulosa cell maturity.
    Buckler HM; Robertson WR; Sun JG; Morris ID
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):552-7. PubMed ID: 1286525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea.
    Petraglia F; Hartmann B; Luisi S; Florio P; Kirchengast S; Santuz M; Genazzani AD; Genazzani AR
    Fertil Steril; 1998 Nov; 70(5):907-12. PubMed ID: 9806574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
    Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea.
    Jonard S; Pigny P; Jacquesson L; Demerle-Roux C; Robert Y; Dewailly D
    Hum Reprod; 2005 Jan; 20(1):101-7. PubMed ID: 15513979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.